GPGA
HAE icon

Grandeur Peak Global Advisors’s Haemonetics HAE Stock Holding History

Grandeur Peak Global Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Sell
13,185
-12,159
-48% -$781K 0.23% 52
2026
Q1 		$1.43M Buy
25,344
+7,192
+40% +$468K 0.33% 40
2025
Q4 		$1.45M Buy
18,152
+3,330
+22% +$224K 0.2% 66
2025
Q3 		$722K Buy
+14,822
New +$917K 0.1% 89

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grandeur Peak Global Advisors's HAE Position: Q2 2026 in Review

Grandeur Peak Global Advisors reduced its Haemonetics (HAE) stake by 48% in Q2 2026, selling an estimated $781K and leaving 13,185 shares worth $989K. The position accounts for 0.23% of the portfolio, ranked #52.

Grandeur Peak Global Advisors first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.45M in Q4 2025. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Grandeur Peak Global Advisors held 13,185 shares of Haemonetics worth $989K as of Q2 2026.
  • Grandeur Peak Global Advisors sold 12,159 Haemonetics shares in Q2 2026, an estimated $781K.
  • Haemonetics made up 0.23% of Grandeur Peak Global Advisors's portfolio in Q2 2026, its #52 holding.
  • Grandeur Peak Global Advisors first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
  • Grandeur Peak Global Advisors's Haemonetics position peaked at $1.45M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Grandeur Peak Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.